Cabaletta Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.

About CABA

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. 

CEO
Steven Nichtberger
CEOSteven Nichtberger
Employees
161
Employees161
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2017
Founded2017
Employees
161
Employees161

CABA Key Statistics

Market cap
302.75M
Market cap302.75M
Price-Earnings ratio
-1.16
Price-Earnings ratio-1.16
Dividend yield
Dividend yield
Average volume
4.62M
Average volume4.62M
High today
$3.34
High today$3.34
Low today
$2.88
Low today$2.88
Open price
$2.99
Open price$2.99
Volume
9.22M
Volume9.22M
52 Week high
$3.67
52 Week high$3.67
52 Week low
$0.9857
52 Week low$0.9857

Stock Snapshot

The current Cabaletta Bio(CABA) stock price is $3.15, with a market capitalization of 302.75M. The stock trades at a price-to-earnings (P/E) ratio of -1.16.

On 2026-01-23, Cabaletta Bio(CABA) stock traded between a low of $2.88 and a high of $3.34. Shares are currently priced at $3.15, which is +9.2% above the low and -5.7% below the high.

Cabaletta Bio(CABA) shares are trading with a volume of 9.22M, against a daily average of 4.62M.

During the past year, Cabaletta Bio(CABA) stock moved between $0.99 at its lowest and $3.67 at its peak.

During the past year, Cabaletta Bio(CABA) stock moved between $0.99 at its lowest and $3.67 at its peak.

CABA News

Simply Wall St 8h
Steven Nichtberger Bought 3.3% More Shares In Cabaletta Bio

Investors who take an interest in Cabaletta Bio, Inc. ( ) should definitely note that the Co-Founder, Steven Nichtberger, recently paid US$2.24 per share to buy...

Steven Nichtberger Bought 3.3% More Shares In Cabaletta Bio
Simply Wall St 1d
Cabaletta Bio, Inc. institutional owners may be pleased with recent gains after 9.7% loss over the past year

Advertisement Key Insights Institutions' substantial holdings in Cabaletta Bio implies that they have significant influence over the company's share price 51...

Cabaletta Bio, Inc. institutional owners may be pleased with recent gains after 9.7% loss over the past year
TipRanks 2d
Cabaletta Bio Insiders Go on a Buying Spree, Signaling Strong Confidence From the Top

New insider activity at Cabaletta Bio ( (CABA) ) has taken place on January 21, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful i...

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own CABA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.